基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
代表性研究成果:a) 报道了全球首株针对SARS-CoV-2的治疗性单克隆抗体和能有效抑制多个变异毒株的DARPin抑制剂,并解析了其与S蛋白的复合物结构,完成了抗体和抑制剂的成果转化;研制了用于SARS-CoV-2等人呼吸道冠状病毒的蛋白芯片,为相关冠状病毒的血清学调查提供了高通量手段;b) 首次报道了高致病性PEDV变异毒株在中国的流行及其序列特征,并开展了PEDV反向遗传改造、基因工程弱毒疫苗、灭活疫苗和亚单位疫苗的研究;c) 鉴定了PDCoV的受体-氨基肽酶N(APN),并揭示该病毒的来源以及跨物种感染人的潜力;d) 鉴定了MERS-CoV的辅助受体,解析了其S蛋白与辅助受体复合物的结构,阐明了其感染宿主的种属特异性和组织嗜性的分子基础。
Research Interests
Papers共 120 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Hua Cao,Mengjia Zhang, Zheyu Liao,Dongfan Li,Xinglin He,Hailong Ma, Pengfei Li,Xuexiang Yu,Guiqing Peng,Shengsong Xie,Qigai He,Wentao Li
Veterinary Researchno. 1 (2024): 1-11
Manman Yao,Hua Cao,Wentao Li, Zihui Hu,Zhenxiang Rong,Mengge Yin,Linxing Tian,Dayue Hu,Xiangmin Li,Ping Qian
FRONTIERS IN IMMUNOLOGY (2024): 1380220-1380220
Journal of medical virologyno. 3 (2024): e29512-e29512
Gastroenterologyno. 5 (2024): S-1107
Gastroenterologyno. 5 (2024): S-1167
Journal of Nanobiotechnologyno. 1 (2024): 1-13
VIRUS RESEARCH (2024): 199303-199303
Wenhao Liu,Xinglin He,Yance Zhu,Yaqin Li, Zhihao Wang, Pengfei Li,Jiajia Pan, Jiang Wang,Beibei Chu,Guoyu Yang,Mengjia Zhang,Qigai He,
The Journal of biological chemistryno. 7 (2024): 107453-107453
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn